免疫检查点抑制剂治疗诱导的自身免疫多分泌综合征II型和克罗恩病:一个病例报告
Mei-Juan Gao1, Yan Xu2, Wen-Bo Wang2
1Department of Endocrinology, Peking University Shougang Hospital, Beijing 100041, China. gmjluhe@163.com.
World journal of clinical cases
|June 5, 2023
概括
免疫检查点抑制剂 (ICI) 可以导致自身免疫性疾病. 一名接受免疫治疗的患者患上了自身免疫多分泌综合征II型和克罗恩氏症.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了癌症治疗,为转移性疾病患者提供了长期生存.
- 然而,ICI越来越多地与自身免疫性疾病的发展有关.
研究的目的:
- 在接受ICI治疗的患者中报告一个罕见的多系统自身免疫损伤病例.
- 强调在诊断ICI相关不良事件时考虑多系统参与的重要性.
主要方法:
- 一名患有口腔状细胞癌的患者接受了包括特里普里祖马布 (ICI) 在内的联合治疗.
- 患者出现了暗示自身免疫性疾病的症状,包括口渴,腹痛和疲劳.
- 诊断工作包括生物化学测试,手术和对特定治疗 (胰岛素,梅萨拉) 的反应.
主要成果:
- 这名患者被诊断为自身免疫多分泌综合征II型 (APS-2),包括甲状腺炎和1型糖尿病.
- 随后通过手术诊断出克罗恩病 (CD).
- 通过胰岛素治疗糖尿病和梅萨拉治疗克罗恩病,症状有所改善.
结论:
- 癌症免疫疗法可以诱导多个器官系统的损伤.
- 临床医生必须考虑多系统性自身免疫损伤的可能性,当患者在ICI治疗期间出现不明原因的临床症状.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
303
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
303
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
204
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
204
Autoimmune Disorders
529
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
529
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
364
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
364


